Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Badrick T, Parvin C. Letter to the Editor on article Dimech W, Karakaltsas M, Vincini G. Comparison of four methods of establishing control limits for monitoring quality controls in infectious disease serology testing. Clin Chem Lab Med 2018;56:1970–8. Clin Chem Lab Med 2019;57:e71–2.10.1515/cclm-2018-0351Search in Google Scholar PubMed
2. Dimech W, Karakaltsas M, Vincini GA. Comparison of four methods of establishing control limits for monitoring quality controls in infectious disease serology testing. Clin Chem Lab Med 2018;56:1970–8.10.1515/cclm-2018-0351Search in Google Scholar
3. Dimech W, Grangeot-Keros L, Vauloup-Fellous C. Standardization of assays that detect anti-rubella virus IgG antibodies. Clin Microbiol Rev 2016;29:163–74.10.1128/CMR.00045-15Search in Google Scholar PubMed PubMed Central
4. WHO Expert Committee on Biological Standardization – WHO Technical Series, 1011 – Sixty-Eighth Report, 2017 – Section 3.3.4, https://www.who.int/biologicals/publications/en/.Search in Google Scholar
©2019 Walter de Gruyter GmbH, Berlin/Boston